Abstract
Depression is a severe medical illness that can interfere with an individuals self-care behaviors. Depression is prevalent [1], burdensome [2], treatable [3], and costly [4]. Recognizing depression in diabetic individuals is critical because depression may play a role in worse control of diabetes and worse diabetes outcomes [5-10]. Depression also appears to increase the costs associated with treating diabetes [11]. A number of clinical trials have recently focused on whether treatment of depression can lead to improved diabetes outcomes [12-15]. In this review, we examine the present state of knowledge on the interaction of depression and diabetes, discuss the epidemiologic and physiologic evidence for the co-occurrence of these conditions, and describe the ways in which diabetes control is worsened by depression, how depression interferes with diabetes care, and how depression acts to increase costs in diabetics. We focus specifically on interventions to treat depression in patients with diabetes and suggest areas of future research and practice with respect to improving care and outcomes those suffering in the intersection of these diseases.
Keywords: heart diseases, serotonin re-uptake inhibitors, non-diabetic control group, depression
Current Diabetes Reviews
Title: The Interaction of Depression and Diabetes: A Review
Volume: 3 Issue: 4
Author(s): Paul A. Pirraglia and Smita Gupta
Affiliation:
Keywords: heart diseases, serotonin re-uptake inhibitors, non-diabetic control group, depression
Abstract: Depression is a severe medical illness that can interfere with an individuals self-care behaviors. Depression is prevalent [1], burdensome [2], treatable [3], and costly [4]. Recognizing depression in diabetic individuals is critical because depression may play a role in worse control of diabetes and worse diabetes outcomes [5-10]. Depression also appears to increase the costs associated with treating diabetes [11]. A number of clinical trials have recently focused on whether treatment of depression can lead to improved diabetes outcomes [12-15]. In this review, we examine the present state of knowledge on the interaction of depression and diabetes, discuss the epidemiologic and physiologic evidence for the co-occurrence of these conditions, and describe the ways in which diabetes control is worsened by depression, how depression interferes with diabetes care, and how depression acts to increase costs in diabetics. We focus specifically on interventions to treat depression in patients with diabetes and suggest areas of future research and practice with respect to improving care and outcomes those suffering in the intersection of these diseases.
Export Options
About this article
Cite this article as:
Pirraglia A. Paul and Gupta Smita, The Interaction of Depression and Diabetes: A Review, Current Diabetes Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/1573399810703040249
DOI https://dx.doi.org/10.2174/1573399810703040249 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists
Current Drug Targets Therapeutic Potential of Natural Compounds that Regulate the Activity of Protein Kinase C
Current Medicinal Chemistry Progress on the Screening and Analysis of Bioactive Compounds in Traditional Chinese Medicines by Biological Fingerprinting Analysis
Combinatorial Chemistry & High Throughput Screening Bioenergetics and Mitochondrial Dysfunction in Aging: Recent Insights for a Therapeutical Approach
Current Pharmaceutical Design Coil-to-Helix Transition within Phospholamban Underlies Release of Ca- ATPase Inhibition in Response to β-Adrenergic Signaling
Current Enzyme Inhibition The Need for Diagnostic Criteria in Systemic Vasculitis
Current Immunology Reviews (Discontinued) NAD Biosynthesis in Humans - Enzymes, Metabolites and Therapeutic Aspects
Current Topics in Medicinal Chemistry Current Hot Potatoes in Atrial Fibrillation Ablation
Current Cardiology Reviews Pharmacotherapy of Aortic Stenosis-Success or Failure?
Current Pharmaceutical Biotechnology microRNAs: Promising Biomarkers and Therapeutic Targets of Acute Myocardial Ischemia
Current Vascular Pharmacology Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension
Current Vascular Pharmacology Heat Shock Protein-60 and Risk for Cardiovascular Disease
Current Pharmaceutical Design An Inflammation-related Nutrient Pattern is Associated with Both Brain and Cognitive Measures in a Multiethnic Elderly Population
Current Alzheimer Research New Therapeutic Approaches to Arterial Calcification Via Inhibition of Transglutaminase andβ-Catenin Signalin
Current Pharmaceutical Design Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease
Current Vascular Pharmacology Editorial (Epigenetics: A Paradigm Shift in Understanding Alzheimer’s Disease)
Current Alzheimer Research Beneficial Effects of Bioactive Phospholipids: Genomic Bases
Current Nutrition & Food Science A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
Current Pharmaceutical Design Postmenopausal Hypertension: Insights from Rat Models
Current Hypertension Reviews Editorial: Multi-Target in Computer-Aided Drug Design Studies
Current Drug Targets